Physician profile
Chad Wayne Putman
NPI 1184745150
$1,670.12
in general payments reported to CMS, 2019-2025
15 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $44.04 · 2021: $125 · 2022: $322 · 2023: $185 · 2024: $343 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.79 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $355.06 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $323.80 | 2022-2025 | Dupixent |
| Intersect Ent, INC. | $205.78 | 2019-2021 | |
| Glaxosmithkline, LLC. | $192.68 | 2021-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $136.21 | 2021-2025 | |
| Medtronic, INC. | $135.43 | 2024 | Stealthstation S8 Platform |
| Stryker Corporation | $83.88 | 2019-2024 | Na |
| Merck Sharp & Dohme LLC | $50.18 | 2021-2023 | |
| Polynovo North America LLC | $48.12 | 2023 | |
| Inspire Medical Systems, INC. | $38.52 | 2024-2025 | Inspire |
| Smith+Nephew, INC. | $31.79 | 2024 | Tula |
| Olympus America INC. | $22.30 | 2019 | |
| Acclarent, INC | $19.84 | 2019 | |
| Osiris Therapeutics INC. | $14.48 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Putman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.